Elevance Health, Inc. (ELV) reported fourth-quarter 2024 adjusted earnings per share (EPS) of $3.84, which surpassed the Zacks Consensus Estimate by 1.1%. However, the bottom line deteriorated 31.7% year over year.See the Zacks Earnings Calendar to stay ahead of market-making news.Operating revenues of $45 billion rose 6% year over year. Moreover, the top line beat the consensus mark by a whisker.Better-than-expected quarterly results benefited from rising premiums and product revenues. Rising expenses and ...

Financial Data and Key Metrics - The company will discuss its financial results and guidance for Q4 2024 and the outlook for 2025 [4] Business Line Data and Key Metrics - The company has multiple business lines including Government Health Benefits, Commercial Health Benefits, and Carelon, each led by respective presidents [3] Market Data and Key Metrics - No specific market data or key metrics mentioned in the provided content Company Strategy and Industry Competition - The CEO will review the progress made against the company's strategic initiatives and discuss the quarter and the 2025 outlook [4] Management Commentary on Operating Environment and Future Prospects - The CEO will provide insights into the company's strategic progress and future outlook during the call [4] Other Important Information - The conference call is being recorded, and participants are encouraged to present a single question during the Q&A session [2] Q&A Session Summary - No specific questions or answers were provided in the content for the Q&A session

Elevance Health 4Q 2024 Earnings Presentation January 23, 2025 The Value We Deliver We advance whole health through innovative solutions that integrate physical, behavioral, and social care to achieve our purpose of improving the health of humanity For Consumers Simple, Affordable, and Accessible Health Care For Care Providers Deepen Clinical and Business Partnerships 2 1. Simplifying healthcare through enhanced digital capabilities that personalize member experiences 2. Affordability at the core of our inn ...

Key TakeawaysElevance Health reported stronger-than-expected results and raised its dividend as it benefited from higher premiums, acquisitions, and growth in its pharmacy division.Both earnings and revenue exceeded analysts' forecasts on what CEO Gail Boudreaux called "tangible progress in improving our operations."Elevance booted its quarterly dividend $0.08 to $1.71 per share. Shares of Elevance Health (ELV) advanced Thursday after the health insurance provider reported better-than-anticipated results on ...

For the quarter ended December 2024, Elevance Health (ELV) reported revenue of $44.99 billion, up 6% over the same period last year. EPS came in at $3.84, compared to $5.62 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $44.67 billion, representing a surprise of +0.71%. The company delivered an EPS surprise of +1.05%, with the consensus EPS estimate being $3.80.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and ho ...

Michael (Mike) Dion is an FP&A, Corporate Finance, and Small Business expert who spent the last 12 years working in the Fortune 100, building a startup's finance and accounting department, advising small businesses, and guiding non-profit organizations as a board member. He has finance experience across multiple industries, including Telecom, Media and Entertainment, Hospitality, and Construction. He founded F9 Finance, a website that helps Finance professionals accelerate their careers; and simplifies Fina ...

E A R N I N G S R E L E A S E ELEVANCE HEALTH REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS; SETS FULL YEAR 2025 OUTLOOK Indianapolis, IN - January 23, 2025 - Elevance Health, Inc. (NYSE: ELV) reported fourth quarter and full year 2024 results. "As part of our commitment to elevating whole health and advancing health beyond healthcare, we deliver value to the members and care providers we serve by ensuring simple, affordable, and accessible care. Our fourth quarter results demonstrate tangible progress ...

Elevance Health, Inc. (ELV) is set to report fourth-quarter 2024 results on Jan. 23, 2024, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings is currently pegged at $3.82 per share on revenues of $44.67 billion. See the Zacks Earnings Calendar to stay ahead of market-making news.The fourth-quarter earnings estimate remained stable over the past 30 days. However, the bottom-line projection indicates a year-over-year decline of 32%. The Zacks Consensus Estimate for ...

Wall Street analysts forecast that Elevance Health (ELV) will report quarterly earnings of $3.82 per share in its upcoming release, pointing to a year-over-year decline of 32%. It is anticipated that revenues will amount to $44.67 billion, exhibiting an increase of 5.2% compared to the year-ago quarter.The consensus EPS estimate for the quarter has been revised 0.1% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial ...

Company Overview - Elevance Health (NYSE: ELV) is a major health insurance provider in the United States, serving approximately 47 million members [1] - The company appears to be in strong financial condition [1] Stock Performance - Elevance Health's stock has significantly outperformed the overall market [1] Author Background - The author holds a Ph.D. in engineering and has expertise in acoustics and noise research [2] - The author is passionate about finance and stock investment, with a focus on capital appreciation opportunities [2] - The author's investment strategy includes purchasing high-quality undervalued companies and reasonably priced growth companies [2] - The author also invests in dividend-paying stocks that are good companies and correctly priced [2] Note: The content does not provide specific financial data, percentage changes, or detailed industry analysis, so those aspects are not included in the summary